This research project is jointly funded by the ASF and Dup15q Alliance.
UBE3A is a protein that tags other proteins to be disposed of in the cell. It interacts with another protein, HERC2, which also has a similar function. Individuals with both copies of HERC2 deleted have a neurodevelopmental disorder with features similar to Angelman syndrome.
Dr. Trave will study the interaction between UBE3A and HERC2 to regulate important genes for neurodevelopment and better understand how UBE3A and HERC2 work together.
This study aims to:
This should help future studies better understand how UBE3A works with HERC2 to impact brain development.
Watch Dr. Trave discuss the project with Terry Jo Bichell, PhD. Â
The mission of Angelman Syndrome Foundation is to advance the awareness and treatment of Angelman syndrome through education and information, research and support for individuals with Angelman syndrome, their families and other concerned parties. We exist to give all of them a reason to smile, with the ultimate goal of finding a cure.